Skip to main content

Table 2 Sensitivity analysis results of HNSCC PRS with significant associations in the UK Biobank

From: Polygenic risk score-based phenome-wide association study of head and neck cancer across two large biobanks

Phenotype description

Exclusion analysis1

Exclusion analysis2

Exclusion analysis3

OR per SD increase (95% CI)

P-value

OR per SD increase (95% CI)

P-value

OR per SD increase (95% CI)

P-value

HNCSS PRS

 Tobacco use disorder

1.06 (1.04–1.07)

6.83 × 10−14

1.06 (1.05–1.08)

3.41 × 10−15

1.06 (1.04–1.07)

6.84 × 10−14

 Alcoholism

1.06 (1.04–1.08)

5.38 × 10−8

1.06 (1.04–1.09)

6.09 × 10−9

1.06 (1.04–1.08)

5.28 × 10−8

 Alcohol-related disorders

1.08 (1.05–1.11)

6.98 × 10−8

1.08 (1.05–1.11)

1.04 × 10−8

1.08 (1.05–1.11)

6.57 × 10−8

 Emphysema

1.11 (1.06–1.16)

9.15 × 10−6

1.11 (1.06–1.16)

4.92 × 10−6

1.11 (1.06–1.16)

8.41 × 10−6

 Chronic airway obstruction

1.04 (1.02–1.07)

1.20 × 10−4

1.05 (1.02–1.07)

2.70 × 10−5

1.04 (1.02–1.07)

1.12 × 10−4

 Cancer of bronchus; lung

1.08 (1.04–1.13)

6.41 × 10−5

1.08 (1.04–1.13)

5.01 × 10−5

1.08 (1.04–1.13)

6.90 × 10−5

OPC PRS

 Tobacco use disorder

1.05 (1.04–1.07)

5.51 × 10−12

1.05 (1.04–1.07)

2.72 × 10−12

1.05 (1.04–1.07)

2.44 × 10−11

 Cancer of bronchus; lung

1.09 (1.05–1.13)

2.30 × 10−5

1.09 (1.05–1.13)

1.62 × 10−5

1.09 (1.05–1.13)

2.49 × 10−5

 Chronic airway obstruction

1.04 (1.02–1.07)

1.62 × 10−4

1.04 (1.02–1.07)

1.06 × 10−4

1.04 (1.02–1.06)

2.99 × 10−4

OC PRS

 Tobacco use disorder

1.04 (1.02–1.05)

1.36 × 10−6

1.04 (1.02–1.05)

2.42 × 10−7

1.04 (1.02–1.05)

9.64 × 10−7

  1. Abbreviations: HNSCC, head and neck squamous cell carcinoma; OC, oral cavity cancer; OPC, oropharynx cancer; PRS, polygenic risk score; MHC, major histocompatibility complex; SD, standard deviation; OR, odds ratio; CI, confidence interval; PC, principal component
  2. All analyses were adjusted by age, sex, genotype array, and PC 1 to 10
  3. 1Exclusion analysis in which HNSCC cases were excluded from PheWAS
  4. 2Exclusion analysis in which the MHC region was excluded from PRS generation
  5. 3Exclusion analysis in which the MHC region was excluded from PRS generation and HNSCC cases were excluded from PheWAS